[1]Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood,2016,127(20):2391-2405.DOI: 10.1182/blood-2016-03-643544.
[2]Yogarajah M, Tefferi A. Leukemic transformation in myeloproliferative neoplasms: a literature review on risk, characteristics, and outcome[J]. Mayo Clin Proc, 2017,92(7):1118-1128.DOI: 10.1016/j.mayocp.2017.05.010.
[3]Tefferi A, Guglielmelli P, Larson DR, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis[J]. Blood, 2014, 124(16):2507-2513;quiz 2615.DOI: 10.1182/blood-2014-05-579136.